| John E Jones, MD | |
|
61 Whitcher Street Ne, Suite 2100, Marietta, GA 30060-1179 | |
| (770) 423-0595 | |
| (770) 423-0598 |
| Full Name | John E Jones |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 26 Years |
| Location | 61 Whitcher Street Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205875739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 223875 (Massachusetts) | Secondary |
| 2086S0129X | Surgery - Vascular Surgery | 58886 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Wellstar Cobb Hospital | Austell, GA | Hospital |
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Cartersville Medical Center | Cartersville, GA | Hospital |
| Wellstar Paulding Hospital | Hiram, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vascular Surgical Associates, Pc | 6709862212 | 25 |
News Archive
The Dallas Morning News investigates issues of patients safety in the wake of sweeping efforts to reform the health system.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Outbreaks such as the severe acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus (MERS) have afflicted people around the world, yet many people think these trends are on the decline.
Cargill today introduced Clear Valley omega-3 shortening, an industry-first shortening innovation to help bakeries differentiate their products and out-perform competitive brands, at the International Baking Industry Exposition (IBIE) in Las Vegas.
Scientists at Imperial College London have developed a test that uses combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
› Verified 4 days ago
| Entity Name | Kennestone Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649248626 PECOS PAC ID: 3870490816 Enrollment ID: O20031217000515 |
News Archive
The Dallas Morning News investigates issues of patients safety in the wake of sweeping efforts to reform the health system.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Outbreaks such as the severe acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus (MERS) have afflicted people around the world, yet many people think these trends are on the decline.
Cargill today introduced Clear Valley omega-3 shortening, an industry-first shortening innovation to help bakeries differentiate their products and out-perform competitive brands, at the International Baking Industry Exposition (IBIE) in Las Vegas.
Scientists at Imperial College London have developed a test that uses combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
› Verified 4 days ago
| Entity Name | Vascular Surgical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114083532 PECOS PAC ID: 6709862212 Enrollment ID: O20040625000667 |
News Archive
The Dallas Morning News investigates issues of patients safety in the wake of sweeping efforts to reform the health system.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Outbreaks such as the severe acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus (MERS) have afflicted people around the world, yet many people think these trends are on the decline.
Cargill today introduced Clear Valley omega-3 shortening, an industry-first shortening innovation to help bakeries differentiate their products and out-perform competitive brands, at the International Baking Industry Exposition (IBIE) in Las Vegas.
Scientists at Imperial College London have developed a test that uses combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
› Verified 4 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
The Dallas Morning News investigates issues of patients safety in the wake of sweeping efforts to reform the health system.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Outbreaks such as the severe acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus (MERS) have afflicted people around the world, yet many people think these trends are on the decline.
Cargill today introduced Clear Valley omega-3 shortening, an industry-first shortening innovation to help bakeries differentiate their products and out-perform competitive brands, at the International Baking Industry Exposition (IBIE) in Las Vegas.
Scientists at Imperial College London have developed a test that uses combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John E Jones, MD 100 Stoneforest Dr Ste 130, Woodstock, GA 30189-4881 Ph: (770) 423-0595 | John E Jones, MD 61 Whitcher Street Ne, Suite 2100, Marietta, GA 30060-1179 Ph: (770) 423-0595 |
News Archive
The Dallas Morning News investigates issues of patients safety in the wake of sweeping efforts to reform the health system.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Outbreaks such as the severe acute respiratory syndrome (SARS) Middle East respiratory syndrome coronavirus (MERS) have afflicted people around the world, yet many people think these trends are on the decline.
Cargill today introduced Clear Valley omega-3 shortening, an industry-first shortening innovation to help bakeries differentiate their products and out-perform competitive brands, at the International Baking Industry Exposition (IBIE) in Las Vegas.
Scientists at Imperial College London have developed a test that uses combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
› Verified 4 days ago
Dr. Madhavi Jordan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne, Suit 130, Marietta, GA 30060 Phone: 770-428-0462 Fax: 770-427-8001 | |
Dr. James Bradford Depew, MD PC Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Vann St Ne Ste 150, Marietta, GA 30060 Phone: 770-421-1242 Fax: 770-424-6652 | |
Michael Richard Corey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 61 Whitcher St Ne, Suite 2100, Marietta, GA 30060 Phone: 770-423-0595 Fax: 678-391-5055 | |
Dr. David H. Hafner, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 61 Whitcher Street Ne, Suite 2100, Marietta, GA 30060 Phone: 770-423-0595 Fax: 770-874-1614 | |
Julie Marie Duke, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 61 Whitcher St Ne Ste 2100, Marietta, GA 30060 Phone: 770-423-0595 | |
Robert A. Underwood, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 598 Nancy St Nw Ste 250, Marietta, GA 30060 Phone: 770-428-3713 Fax: 770-426-0730 | |
Dr. Daniella Barker Kington, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne Ste 130, Marietta, GA 30060 Phone: 770-428-0462 |